Predicting the response to cancer treatment

Israel’s Oncohost is working with Israel’s Technion to develop cutting-edge technology to characterize, analyze and predict patient response and resistance to cancer therapy. This enables personalized treatment strategies with improved outcomes & reduced side effects.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *